Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Koeller K, Shih R
PKA closes adenosine triphosphate (ATP)-dependent potassium (KATP) channels, depolarizes -cell membranes, and opens voltage-dependent calcium channels
Certain agents (liraglutide, semaglutide, dulaglutide) reduce major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease
Licensed from Chugai Pharmaceutical in 2018, orforglipron represents a significant advancement in the treatment of type 2 diabetes and obesity
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
